Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Opthea Limited ( (AU:OPT) ) is now available.
Opthea Limited has announced the application for the quotation of 1,221 new ordinary fully paid securities on the Australian Securities Exchange, effective February 10, 2025. This move may enhance Opthea’s market position by potentially increasing its visibility and access to capital, which could have implications for its stakeholders.
More about Opthea Limited
Opthea Limited operates within the biotechnology industry, focusing on developing therapies for eye diseases.
YTD Price Performance: 9.09%
Average Trading Volume: 9,900
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $868.9M
For detailed information about OPT stock, go to TipRanks’ Stock Analysis page.